Melanoma,Skin Cancer Phase 3 Trial: Fianlimab + Cemiplimab vs. Pembrolizumab in High-Risk Melanoma Jul 31, 2023
Melanoma,Skin Cancer 1L Atezolizumab With Vemurafenib and Cobimetinib Improves OS in BRAFV600 Advanced Melanoma Jun 01, 2023
Melanoma,Skin Cancer NNT and NNH Utilized to Assess the Efficacy and Safety of Adjuvant Therapies in Melanoma Jun 01, 2023
Melanoma,Skin Cancer Tumor Biomarker Analysis of Encorafenib + Binimetinib in Advanced Melanoma Jun 01, 2023
Melanoma,Skin Cancer Before or After: The Debate on Pembrolizumab Administration for High-Risk Melanoma Jun 01, 2023
Melanoma,Skin Cancer Adjuvant Pembrolizumab or Placebo in Stage III Melanoma: 5-Year Analysis May 22, 2023
Melanoma,Skin Cancer CheckMate-915 Study Shows Improved Survival Rates for Resected Stage III/IV Melanoma Patients Apr 20, 2023
